1. DOP45 Adequate infliximab exposure during the induction phase is associated with early complete fistula response in patients with fistulizing Crohn's disease: a post-hoc analysis of the ACCENT-2 trial. (25th January 2019) Authors: Vande Casteele, N; Papamichael, K; Jeyarajah, J; Osterman, M T; Cheifetz, A S Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗